These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7735147)

  • 1. Ipsilateral suppression effects on transient evoked otoacoustic emission.
    Tavartkiladze GA; Frolenkov GI; Kruglov AV; Artamasov SV
    Br J Audiol; 1994; 28(4-5):193-204. PubMed ID: 7735147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipsilateral suppression of transient evoked otoacoustic emission: role of the medial olivocochlear system.
    Tavartkiladze GA; Frolenkov GI; Artamasov SV
    Acta Otolaryngol; 1996 Mar; 116(2):213-8. PubMed ID: 8725517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of evoking stimulus level on the neural suppression of transient evoked otoacoustic emissions.
    Ryan S; Kemp DT
    Hear Res; 1996 May; 94(1-2):140-7. PubMed ID: 8789819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital subtraction method for transient evoked otoacoustic emission recording with ipsilateral noise suppression: an application to stimulus artifact reduction.
    Arslan RB; Ozdamar O; Ulgen Y
    Audiology; 2001; 40(2):55-62. PubMed ID: 11409763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient evoked otoacoustic emission with unexpectedly short latency.
    Kruglov AV; Artamasov SV; Frolenkov GI; Tavartkiladze GA
    Acta Otolaryngol; 1997 Mar; 117(2):174-8. PubMed ID: 9105442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
    Prieve BA; Calandruccio L; Fitzgerald T; Mazevski A; Georgantas LM
    Ear Hear; 2008 Aug; 29(4):533-42. PubMed ID: 18469719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in otoacoustic emission during the glycerol test in the ears of patients with Meniere's disease].
    Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Shibata T; Yamane H; Kusuki M; Wada T; Uyama T
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Jun; 104(6):682-93. PubMed ID: 11494522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of cochlear active mechanisms in tinnitus subjects with normal hearing sensitivity: multiparametric recording of evoked otoacoustic emissions and contralateral suppression.
    Paglialonga A; Del Bo L; Ravazzani P; Tognola G
    Auris Nasus Larynx; 2010 Jun; 37(3):291-8. PubMed ID: 19879078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral suppression of TEOAE. Attempts to find a latency.
    Lind O
    Br J Audiol; 1994; 28(4-5):219-25. PubMed ID: 7735150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Sensorineural Hearing Loss Using Various Transient-Evoked Otoacoustic Emission Stimulus Conditions.
    Putterman DB; Keefe DH; Hunter LL; Garinis AC; Fitzpatrick DF; McMillan GP; Feeney MP
    Ear Hear; 2017; 38(4):507-520. PubMed ID: 28437273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efferent-mediated reduction in cochlear gain does not alter tuning estimates from stimulus-frequency otoacoustic emission group delays.
    Bhagat SP; Kilgore C
    Neurosci Lett; 2014 Jan; 559():132-5. PubMed ID: 24333175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electric-acoustic forward masking in cochlear implant users with ipsilateral residual hearing.
    Imsiecke M; Krüger B; Büchner A; Lenarz T; Nogueira W
    Hear Res; 2018 Jul; 364():25-37. PubMed ID: 29673567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.
    Bolay H; Bayazit YA; Gündüz B; Ugur AK; Akçali D; Altunyay S; Ilica S; Babacan A
    Cephalalgia; 2008 Apr; 28(4):309-17. PubMed ID: 18279433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral and ipsilateral 'suppression' of evoked otoacoustic emissions at high stimulation rates.
    Thornton AR
    Br J Audiol; 1994; 28(4-5):227-34. PubMed ID: 7735151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behaviour of delayed evoked otoacoustic emission under forward masking paradigm.
    Gobsch H; Kevanishvili Z; Gamgebeli Z; Gvelesiani T
    Scand Audiol; 1992; 21(3):143-8. PubMed ID: 1439499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between auditory threshold and evoked otoacoustic emissions.
    Wagner W; Plinkert PK
    Eur Arch Otorhinolaryngol; 1999; 256(4):177-88. PubMed ID: 10337508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral suppression of transient-evoked otoacoustic emissions in children with sickle cell disease.
    Stuart A; Preast JL
    Ear Hear; 2012; 33(3):421-9. PubMed ID: 22246207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contralateral modification of transitory evoked otoacoustic emissions].
    Ganz M; von Specht H; Kevanishvili Z
    Laryngorhinootologie; 1997 May; 76(5):278-83. PubMed ID: 9280414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swept-tone transient-evoked otoacoustic emissions.
    Bennett CL; Özdamar Ö
    J Acoust Soc Am; 2010 Oct; 128(4):1833-44. PubMed ID: 20968356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prolonged contralateral acoustic stimulation on transient evoked otoacoustic emissions.
    van Zyl A; Swanepoel D; Hall JW
    Hear Res; 2009 Aug; 254(1-2):77-81. PubMed ID: 19401226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.